Suppr超能文献

经皮腰椎减压微创(®)治疗腰椎管狭窄症的长期疗效。

Long-term results of percutaneous lumbar decompression mild(®) for spinal stenosis.

机构信息

Evidence Based Pain Management Research and Education, Cleveland Clinic, Cleveland, Ohio 44195, USA.

出版信息

Pain Pract. 2012 Mar;12(3):184-93. doi: 10.1111/j.1533-2500.2011.00481.x. Epub 2011 Jun 16.

Abstract

BACKGROUND

Lumbar spinal stenosis (LSS) generally occurs from a combination of degenerative changes occurring in the lumbar spine. These include hypertrophy of ligamentum flavum, facet joint arthritic changes and bulging of the intervertebral disk. Spinal stenosis leads to compression of the lumbar neural elements (cauda equina), which manifests as low back and leg pain especially on standing and walking known as "neurogenic claudication." Current treatment options for LSS are varied. Conservative management, including physical therapy with/without epidural steroid injections, may be adequate for mild stenosis. Surgical decompression is reserved for severe cases and results in variable degrees of success. Patients with moderate-to-severe LSS having ligamentum flavum hypertrophy as a key contributor are generally inappropriately treated or undertreated. This is due to ineffectiveness of conservative therapy and possibility that major surgical compression might be too aggressive. Percutaneous decompression offers a possible solution for this patient population.

METHODS

One-year follow-up study was conducted at 11 U.S. sites. Study cohort included 58 mild(®) percutaneous decompression patients who underwent 170 procedures, the majority treated bilaterally at one or two lumbar levels. Outcome measures included the visual analog scale (VAS), Oswestry Disability Index (ODI), Zurich Claudication Questionnaire (ZCQ), and SF-12v2(®) Health Survey.

RESULTS

No major mild(®) device or procedure-related complications were reported. One-year data showed significant reduction of pain as measured by VAS. Improvement in physical functionality, mobility, and disability was significant as measured by ZCQ, SF-12v2, and ODI.

CONCLUSIONS

At 1 year this 58-patient cohort demonstrated continued excellent safety profile of the mild(®) procedure and equally important, showed long-term pain relief and improved functionality.

摘要

背景

腰椎管狭窄症(LSS)通常是由腰椎退行性改变引起的。这些改变包括黄韧带肥厚、小关节关节炎改变和椎间盘膨出。椎管狭窄导致腰椎神经受压(马尾神经),表现为腰痛和腿痛,尤其是站立和行走时,称为“神经性跛行”。目前治疗腰椎管狭窄症的方法多种多样。包括物理治疗和/或硬膜外类固醇注射在内的保守治疗可能对轻度狭窄有效。手术减压适用于严重病例,其效果因人而异。有中度至重度腰椎管狭窄症且黄韧带肥厚为主要病因的患者,治疗方法通常不合适或治疗不足。这是由于保守治疗无效,且可能认为主要手术减压过于激进。经皮减压为这部分患者提供了一种可能的解决方案。

方法

在美国 11 个地点进行了为期 1 年的随访研究。研究队列包括 58 名轻度(®)经皮减压患者,他们共接受了 170 次手术,大多数患者在 1 个或 2 个腰椎水平进行双侧治疗。疗效评估指标包括视觉模拟评分(VAS)、Oswestry 残疾指数(ODI)、苏黎世跛行问卷(ZCQ)和 SF-12v2(®)健康调查。

结果

未报告与轻度(®)设备或手术相关的重大并发症。1 年数据显示,VAS 测量的疼痛明显减轻。ZCQ、SF-12v2 和 ODI 测量的身体功能、活动能力和残疾的改善具有统计学意义。

结论

在 1 年时,这 58 名患者的队列表现出持续的良好安全性,同样重要的是,该研究表明长期缓解疼痛和改善功能。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验